These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29199166)

  • 21. Gastroesophageal reflux disease and patterns of reflux in patients with idiopathic pulmonary fibrosis using hypopharyngeal multichannel intraluminal impedance.
    Hoppo T; Komatsu Y; Jobe BA
    Dis Esophagus; 2014 Aug; 27(6):530-7. PubMed ID: 23107023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of environment and lifestyle on gastroesophageal reflux disease.
    Sonnenberg A
    Dig Dis; 2011; 29(2):229-34. PubMed ID: 21734389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term and long-term effect of diaphragm biofeedback training in gastroesophageal reflux disease: an open-label, pilot, randomized trial.
    Sun X; Shang W; Wang Z; Liu X; Fang X; Ke M
    Dis Esophagus; 2016 Oct; 29(7):829-836. PubMed ID: 26227494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era.
    Herregods TV; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1202-13. PubMed ID: 26053301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiology and pathogenesis of gastroesophageal reflux disease.
    Mikami DJ; Murayama KM
    Surg Clin North Am; 2015 Jun; 95(3):515-25. PubMed ID: 25965127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant-mediated gastroesophageal reflux disease.
    Brahm NC; Kelly-Rehm MC
    Consult Pharm; 2011 Apr; 26(4):274-8. PubMed ID: 21486738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced lesions of the oesophageal mucosa.
    Prescrire Int; 2015 Sep; 24(163):210-1, 213. PubMed ID: 26417631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology and diagnosis of gastroesophageal reflux disease.
    Bozymski EM
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S4-6. PubMed ID: 8475926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological study on the incidence of gastroesophageal reflux disease symptoms in patients in acute treatment with NSAIDs.
    Martín-de-Argila C; Martínez-Jiménez P
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):27-33. PubMed ID: 23265146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
    Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
    Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of common cardiac drugs on gastroesophageal reflux disease: multicenter questionnaire survey.
    Nakaji G; Fujihara M; Fukata M; Yasuda S; Odashiro K; Maruyama T; Akashi K
    Int J Clin Pharmacol Ther; 2011 Sep; 49(9):555-62. PubMed ID: 21888868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of gastroesophageal reflux and Barrett esophagus.
    Buttar NS; Falk GW
    Mayo Clin Proc; 2001 Feb; 76(2):226-34. PubMed ID: 11213315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association between acid reflux and esophageal dysmotility in patients with gastroesophageal reflux disease].
    Yi ZH; Feng L; Wen MY; Liu JR; Yang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):480-3. PubMed ID: 24941823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The acid pocket as the pathogenic basis and therapeutic target in gastroesophageal reflux disease].
    Bordin DS
    Ter Arkh; 2014; 86(2):76-81. PubMed ID: 24772513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Esophageal complications of non steroidal antiinflammatory drugs].
    Bigard MA; Pelletier AL
    Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C58-61. PubMed ID: 15366675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of gastroesophageal reflux disease among hospital employees.
    Ercelep OB; Caglar E; Dobrucali A
    Dis Esophagus; 2014 Jul; 27(5):403-8. PubMed ID: 23020266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Obesity and gastroesophageal reflux disease].
    Gómez Escudero O; Herrera Hernández MF; Valdovinos Díaz MA
    Rev Invest Clin; 2002; 54(4):320-7. PubMed ID: 12415956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.